301 related articles for article (PubMed ID: 27900443)
1. P450
Beyer N; Kulig JK; Bartsch A; Hayes MA; Janssen DB; Fraaije MW
Appl Microbiol Biotechnol; 2017 Mar; 101(6):2319-2331. PubMed ID: 27900443
[TBL] [Abstract][Full Text] [Related]
2. Exploring PTDH-P450BM3 Variants for the Synthesis of Drug Metabolites.
Beyer N; Kulig JK; Fraaije MW; Hayes MA; Janssen DB
Chembiochem; 2018 Feb; 19(4):326-337. PubMed ID: 29181885
[TBL] [Abstract][Full Text] [Related]
3. Functional interactions in cytochrome P450BM3: flavin semiquinone intermediates, role of NADP(H), and mechanism of electron transfer by the flavoprotein domain.
Murataliev MB; Klein M; Fulco A; Feyereisen R
Biochemistry; 1997 Jul; 36(27):8401-12. PubMed ID: 9204888
[TBL] [Abstract][Full Text] [Related]
4. Hoodwinking Cytochrome P450BM3 into Hydroxylating Non-Native Substrates by Exploiting Its Substrate Misrecognition.
Shoji O; Aiba Y; Watanabe Y
Acc Chem Res; 2019 Apr; 52(4):925-934. PubMed ID: 30888147
[TBL] [Abstract][Full Text] [Related]
5. Design of a cytochrome P450BM3 reaction system linked by two-step cofactor regeneration catalyzed by a soluble transhydrogenase and glycerol dehydrogenase.
Mouri T; Shimizu T; Kamiya N; Goto M; Ichinose H
Biotechnol Prog; 2009; 25(5):1372-8. PubMed ID: 19725101
[TBL] [Abstract][Full Text] [Related]
6. Effect of Mutation and Substrate Binding on the Stability of Cytochrome P450BM3 Variants.
Geronimo I; Denning CA; Rogers WE; Othman T; Huxford T; Heidary DK; Glazer EC; Payne CM
Biochemistry; 2016 Jun; 55(25):3594-606. PubMed ID: 27267136
[TBL] [Abstract][Full Text] [Related]
7. Expanding the applicability of cytochrome P450s and other haemoproteins.
Ariyasu S; Stanfield JK; Aiba Y; Shoji O
Curr Opin Chem Biol; 2020 Dec; 59():155-163. PubMed ID: 32781431
[TBL] [Abstract][Full Text] [Related]
8. Functional interactions in cytochrome P450BM3. Fatty acid substrate binding alters electron-transfer properties of the flavoprotein domain.
Murataliev MB; Feyereisen R
Biochemistry; 1996 Nov; 35(47):15029-37. PubMed ID: 8942669
[TBL] [Abstract][Full Text] [Related]
9. Crystallographic insights into a cobalt (III) sepulchrate based alternative cofactor system of P450 BM3 monooxygenase.
Panneerselvam S; Shehzad A; Mueller-Dieckmann J; Wilmanns M; Bocola M; Davari MD; Schwaneberg U
Biochim Biophys Acta Proteins Proteom; 2018 Jan; 1866(1):134-140. PubMed ID: 28739446
[TBL] [Abstract][Full Text] [Related]
10. Biochemical characterization of rat P450 2C11 fused to rat or bacterial NADPH-P450 reductase domains.
Helvig C; Capdevila JH
Biochemistry; 2000 May; 39(17):5196-205. PubMed ID: 10819987
[TBL] [Abstract][Full Text] [Related]
11. A tailor-made, self-sufficient and recyclable monooxygenase catalyst based on coimmobilized cytochrome P450 BM3 and glucose dehydrogenase.
Valikhani D; Bolivar JM; Dennig A; Nidetzky B
Biotechnol Bioeng; 2018 Oct; 115(10):2416-2425. PubMed ID: 30036448
[TBL] [Abstract][Full Text] [Related]
12. Combinatorial alanine substitution enables rapid optimization of cytochrome P450BM3 for selective hydroxylation of large substrates.
Lewis JC; Mantovani SM; Fu Y; Snow CD; Komor RS; Wong CH; Arnold FH
Chembiochem; 2010 Dec; 11(18):2502-5. PubMed ID: 21108271
[TBL] [Abstract][Full Text] [Related]
13. Process intensification for cytochrome P450 BM3-catalyzed oxy-functionalization of dodecanoic acid.
Buergler MB; Dennig A; Nidetzky B
Biotechnol Bioeng; 2020 Aug; 117(8):2377-2388. PubMed ID: 32369187
[TBL] [Abstract][Full Text] [Related]
14. Mechanistic investigation of a highly active phosphite dehydrogenase mutant and its application for NADPH regeneration.
Woodyer R; Zhao H; van der Donk WA
FEBS J; 2005 Aug; 272(15):3816-27. PubMed ID: 16045753
[TBL] [Abstract][Full Text] [Related]
15. Laboratory-Scale Hydroxylation of Steroids by P450
Hoebenreich S; Spinck M; Nett N
Methods Mol Biol; 2017; 1645():239-257. PubMed ID: 28710633
[TBL] [Abstract][Full Text] [Related]
16. Expression, purification, and characterization of Bacillus subtilis cytochromes P450 CYP102A2 and CYP102A3: flavocytochrome homologues of P450 BM3 from Bacillus megaterium.
Gustafsson MC; Roitel O; Marshall KR; Noble MA; Chapman SK; Pessegueiro A; Fulco AJ; Cheesman MR; von Wachenfeldt C; Munro AW
Biochemistry; 2004 May; 43(18):5474-87. PubMed ID: 15122913
[TBL] [Abstract][Full Text] [Related]
17. Filling a hole in cytochrome P450 BM3 improves substrate binding and catalytic efficiency.
Huang WC; Westlake AC; Maréchal JD; Joyce MG; Moody PC; Roberts GC
J Mol Biol; 2007 Oct; 373(3):633-51. PubMed ID: 17868686
[TBL] [Abstract][Full Text] [Related]
18. Chimeragenesis of the fatty acid binding site of cytochrome P450BM3. Replacement of residues 73-84 with the homologous residues from the insect cytochrome P450 CYP4C7.
Murataliev MB; Trinh LN; Moser LV; Bates RB; Feyereisen R; Walker FA
Biochemistry; 2004 Feb; 43(7):1771-80. PubMed ID: 14967018
[TBL] [Abstract][Full Text] [Related]
19. Molecular Determinants of Substrate Affinity and Enzyme Activity of a Cytochrome P450
Geronimo I; Denning CA; Heidary DK; Glazer EC; Payne CM
Biophys J; 2018 Oct; 115(7):1251-1263. PubMed ID: 30224054
[TBL] [Abstract][Full Text] [Related]
20. Key mutations alter the cytochrome P450 BM3 conformational landscape and remove inherent substrate bias.
Butler CF; Peet C; Mason AE; Voice MW; Leys D; Munro AW
J Biol Chem; 2013 Aug; 288(35):25387-25399. PubMed ID: 23828198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
